April 9, 2010
The U.S. Court of Appeals for the Federal Circuit affirmed on April 1 a lower court’s dismissal of a declaratory judgment action against the holder of patents related to a device for treating chronic wounds. The court rejected arguments that lawsuits initiated by the patent holder after the declaratory judgment action was filed created a controversy under the Declaratory Judgment Act. Kinetic Concepts, Inc. holds rights in five patents; Innovative Therapies, Inc., established by several former Kinetic employees, sought a declaration in 2007 that Kinetic’s patents were invalid. Kinetic moved to dismiss the action for lack of jurisdiction under the Declaratory Judgment Act. A district court judge found there was no actual controversy, and dismissed the claim. Innovative appealed, but Judge Pauline Newman rejected Innovative’s arguments that the district court had erred in its finding that certain factors did not establish the existence of a controversy of “sufficient immediacy and reality,” to establish jurisdiction under MedImmune, Inc. v. Genentech, Inc. Kinetic is represented in this matter by Finnegan partner Donald Dunner.
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Commentary
U.S. Judge Rules Forum-Selection Clause Bars Zync from Pursuing ITC Trade Secret Case
June 15, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.